Ariel Ramirez Cortes | Immunology and Microbiology | Best Researcher Award

Published on by World Top Scientists

Prof. Ariel Ramirez Cortes | Immunology and Microbiology | Best Researcher Award

Researcher | Universidad Nacional Autónoma de México | Mexico

Prof. Ariel Ramírez Cortes is an accomplished academic and researcher with extensive training spanning undergraduate, graduate, doctoral, and postdoctoral studies, primarily in health sciences, public health, and nursing research. He has consistently engaged in professional development through numerous specialized courses, workshops, seminars, and symposia, both nationally and internationally, covering topics from statistics and immunology to advanced medical care and research methodologies. His participation in conferences and interdisciplinary forums reflects a strong commitment to scientific exchange and collaboration. As an educator, he has taught a wide range of subjects, including anatomy, physiology, critical care nursing, and quantitative research methods, contributing significantly to the formation of future professionals. His profile is marked by a dedication to continuous learning, interdisciplinary integration, and the advancement of healthcare education. These qualities, combined with his active engagement in academic and research activities, position him as a strong and capable candidate for high-level professional recognition.

Profiles: Google Scholar

Featured Publications

1. Arenas-Montaño, G., Hernández, E. A. G., Ramírez-Cortes, A., Rodríguez, E. A., & others. (2022). Gender-based violence and its prevention in university nursing areas. World Journal of Advanced Research and Reviews, 14(2), 246–252.

2. Trujillo, J. A., Cortes, A. R., & Guajardo, L. C. (2020). Estrategia para disminuir la prevalencia de síndrome metabólico en adolescentes con sobrepeso/obesidad. CuidArte, 6(11), 6–15.

3. Villaseñor, K. A. P., Cabrera, N. C., Rentería, M. L. J., & Cortes, A. R. (2020). Estudio cuali-cuantitativo sobre cómo perciben los estudiantes de pregrado en psicología sus conocimientos éticos profesionales. Revista Electrónica de Psicología Iztacala, 23(2).

4. Piñón-Zárate, G., Hernández-Téllez, B., Ramírez-Cortés, A., Jarquín-Yáñez, K., & others. (2025). Chitosan microparticles coupled with MAGE-AX and CpGs as a treatment for murine melanoma. Pharmaceutics, 17(7), 932.

5. Ramírez Cortes, A., Castell Rodríguez, A. E., Herrera Enrique, M., & others. (2025). Preparation of nanoparticles for evaluation of antitumor effect in a melanoma model. European Journal of Immunology, 54, 769.

Prof. Ariel Ramírez Cortes advances health sciences through research that strengthens public health, immunology, and evidence-based nursing practice. His commitment to interdisciplinary education and scientific collaboration fosters better-prepared healthcare professionals and contributes to improved population well-being.

Burak Ezer | Immunology and Microbiology | Best Researcher Award

Published on by World Top Scientists

Dr. Burak Ezer | Immunology and Microbiology | Best Researcher Award

Medical Doctor | Beyhekim Training and Research Hospital | Turkey

Dr. Burak Ezer is a dedicated medical microbiologist whose work spans clinical microbiology, infectious diseases, and rare pathogen case studies. He has made significant contributions to the understanding of fungal and bacterial infections, chronic hepatitis, and viral seroprevalence, publishing extensively in both national and international peer-reviewed journals. His research emphasizes the clinical and diagnostic aspects of emerging pathogens, antimicrobial resistance, and serological markers, often employing advanced molecular and automated techniques. Dr. Ezer has demonstrated strong academic leadership through his role as corresponding author on numerous publications, participation in international and national conferences, and editorial and peer-review responsibilities for indexed journals. He has also contributed to book chapters, further consolidating his expertise in hepatitis and herpesvirus research. His collaborative efforts with multiple co-authors reflect a broad network and commitment to advancing medical science. Dr. Ezer’s measurable research impact is documented through Scopus, showing 9 publications, 1 citation, and an h-index of 1.

Profiles: Scopus | ORCID

Featured Publications

1. Ezer, B., Taşkın, Z., Kaba, K., Uğraklı, S., & Doğan, M. (2025). Comparison of automated systems using liquid microdilution for the determination of colistin resistance in Klebsiella pneumoniae strains. Turkish Bulletin of Hygiene and Experimental Biology.

2. Ezer, B., Esen, H. S., Ugrakli, S., Iyisoy, M. S., & Ozdemir, M. (2025, October 8). Association between serum HBV DNA levels and CCL-20, CD8a, CXCL-16, and GDF-15 in patients with chronic hepatitis B. Viruses.

3. Ezer, B., Ceylan, A., Arazi-Kan, S. N., Uğraklı, S., Bulut, R., & Demircioğlu, S. (2025, September 29). Fungemia caused by Fusarium proliferatum species complex in a patient with acute myeloid leukemia: A rare case report. Klimik Journal.

4. Ezer, B., Uğraklı, S., & Kasapoğlu, E. (2025, September 25). Kandidemi vakalarında hematolojik parametrelerin Albicans ve non-Albicans Candida türleri ile ilişkisi. Flora: The Journal of Infectious Diseases and Clinical Microbiology.

5. Ezer, B., Çiftci, H. S., Uğraklı, S., Bulut, R., & Gök, F. (2025, August 29). Candida auris fungemia confirmed by Sanger sequencing method: A rare case report. Genel Tıp Dergisi.

Anish Maskey | Immunology and Microbiology | Best Researcher Award

Published on by World Top Scientists

Dr. Anish Maskey | Immunology and Microbiology | Best Researcher Award

Postdoctoral Fellow at New York Medical College, United States

Dr. Anish R. Maskey is a dedicated postdoctoral fellow at the Department of Pathology, Microbiology & Immunology at New York Medical College, with a specialized focus on allergy, immunology, and infectious diseases. With an in-depth understanding of translational research, he integrates bench-to-bedside approaches, concentrating on biomarker discovery, immune response profiling, and therapeutic evaluation for allergic and inflammatory conditions. Over the past six years, he has built a strong scientific portfolio in both academic and clinical research settings, with active involvement in designing, executing, and analyzing preclinical studies using in-vitro systems, human samples, and murine models. His collaborative nature and leadership skills are evident through his mentorship of over 25 trainees, active role in multi-institutional conferences, and contribution to peer-reviewed journals. Dr. Maskey’s publication record includes multiple first-author and collaborative studies in prominent journals like Frontiers in Allergy, Cells, and The Journal of Inflammation Research. His scientific acumen is matched by his commitment to education and community-building in science. As a member of multiple professional societies and editorial boards, he continues to shape the future of immunological research while fostering international collaboration and integrative medical approaches. His work represents a blend of scientific excellence, innovation, and societal impact.

Professional Profile

Education

Dr. Anish R. Maskey holds a Ph.D. in Pathology, Microbiology, and Immunology from New York Medical College, which he earned in 2023 with a commendable CGPA of 3.75/4. His doctoral research was centered on discovering small molecule compounds—particularly from Traditional Chinese Medicine—as novel therapeutics for eosinophilic esophagitis. This body of work laid the foundation for his expertise in allergic diseases, immunomodulation, and translational medicine. Prior to his Ph.D., Dr. Maskey completed his Bachelor of Science in Medical Laboratory Technology from the Institute of Medicine in Kathmandu, Nepal, graduating in 2016 with a strong academic record of 72%. His educational journey reflects a continual evolution from clinical laboratory sciences to cutting-edge immunological research, underpinned by rigorous training in microbiology, molecular biology, and clinical diagnostics. Beyond formal education, he has also actively pursued professional development through certifications in clinical trial ethics, laboratory safety, peer reviewing, and biomedical research compliance under platforms such as CITI and Elsevier. These educational milestones not only showcase Dr. Maskey’s technical proficiency but also his commitment to lifelong learning, scientific integrity, and the ethical conduct of human and animal research. His academic background enables him to operate seamlessly at the intersection of clinical science and laboratory innovation.

Professional Experience

Dr. Maskey currently serves as a postdoctoral fellow at New York Medical College, where he works under the mentorship of Dr. Xiu-Min Li on multiple NIH-funded projects related to allergic diseases, microbiome therapy, and drug discovery. He is the Co-Investigator or Co-Principal Investigator on several high-impact translational research studies involving human clinical samples and murine models. His work explores the therapeutic efficacy of natural compounds on conditions such as eczema, food allergies, eosinophilic esophagitis, and antibiotic-resistant infections. Previously, during his Ph.D. candidacy (2018–2023), he led key investigations on chronic inflammatory diseases and mentored junior researchers while also teaching advanced immunology and microbiology courses. Dr. Maskey has authored or co-authored over 15 peer-reviewed publications and actively contributes as an editorial board member and peer reviewer for journals such as Frontiers in Allergy and The FASEB Journal. In his leadership roles, he has managed research teams, coordinated research conferences, and overseen protocol development and compliance for IRB and IACUC projects. His professional experience reflects a dynamic integration of teaching, research, mentorship, and administration, underlining his preparedness for independent academic or industry-based scientific leadership roles in immunology, microbiology, and translational medicine.

Research Interests

Dr. Anish R. Maskey’s research interests span allergy and immunology, host-pathogen interactions, microbiome-based therapy, and immune modulation using natural compounds. His primary focus lies in discovering and validating biomarkers for allergic diseases, including food allergies, eczema, eosinophilic esophagitis, and drug-resistant infections. Dr. Maskey is particularly interested in translational and integrative approaches to treating chronic inflammation by bridging clinical medicine with basic science. Through his ongoing work on immune profiling, he explores cytokine signaling, IgE-mediated hypersensitivity, mast cell activation, and epigenetic regulation of Th2 responses. He has established various murine models for food allergies, eczema, and Staphylococcus aureus infections to test the efficacy and mechanisms of plant-based therapeutics like berberine and ganoderic acid. Additionally, he investigates the skin and gut microbiomes’ roles in disease progression and recovery, utilizing both in-vivo and ex-vivo models. His interest also extends to nanoparticle drug delivery and immune memory formation. Dr. Maskey’s ultimate goal is to facilitate the development of safer, non-steroidal treatment options that are effective, personalized, and rooted in natural product pharmacology. His work contributes meaningfully to both the scientific community and clinical practice, offering promising alternatives for managing and preventing allergic and inflammatory disorders.

Awards and Honors

Dr. Anish R. Maskey has been the recipient of numerous prestigious awards and honors recognizing his academic excellence, innovative research, and impactful scientific contributions. He has won multiple travel scholarships from the American Academy of Allergy, Asthma & Immunology (AAAAI) from 2022 to 2025, allowing him to present his research at major national conferences. In 2023, he received the APFED travel grant and earned the Outstanding Abstract Award at Touro Research Day in 2024. He also secured second place for oral abstract presentation at the 1st PMI Conference at New York Medical College and was a runner-up in the ASBMB’s “Science in a Flash” competition. His publications have gained recognition as Top Cited and Top Downloaded articles by WILEY and The FASEB Journal. Furthermore, Dr. Maskey has been appointed as an Editorial Board Member for the International Journal of Infectious Diseases and Therapy and The FASEB Journal’s Early Career Researcher Board. His service as a peer reviewer for journals under Cell Press, Frontiers, MDPI, and Dove Medical Press further underscores his credibility and scientific leadership. These accolades collectively affirm his rising influence in the fields of immunology and translational medicine.

Conclusion

Dr. Anish R. Maskey is an outstanding candidate for the Best Researcher Award, especially in the category of early-career/postdoctoral researchers. His contributions to the fields of immunology and infectious diseases are substantive, innovative, and multidisciplinary. His leadership in research, commitment to mentoring, and active scholarly engagement make him exceptionally deserving of recognition.

Publications Top Notes

  • Title: A small molecule compound berberine as an orally active therapeutic candidate against COVID‐19 and SARS
    First Author: Wang ZZ
    Year: 2021
    Citations: 68

  • Title: Cytochrome P450 3A4 suppression by epimedium and kaempferol leads to synergistic anti-inflammatory effect with corticosteroid
    First Author: Li K
    Year: 2023
    Citations: 12

  • Title: Inhibition of pathologic immunoglobulin E in food allergy by EBF-2 and berberine with immunometabolism regulation
    First Author: Yang N
    Year: 2023
    Citations: 11

  • Title: Induction of severe eosinophilic esophagitis and multi-organ inflammation by airborne allergens
    First Author: Maskey A
    Year: 2022
    Citations: 9

  • Title: Formononetin inhibits B cell-IgE production by regulating XBP-1
    First Author: Yang N
    Year: 2023
    Citations: 7

  • Title: Anti-IgE effect of arctigenin on food allergy with a distinct transcriptome profile
    First Author: Cao M
    Year: 2022
    Citations: 6

  • Title: Computational analysis of 7,4’-Dihydroxyflavone on eosinophilic esophagitis
    First Author: Maskey AR
    Year: 2022
    Citations: 3

  • Title: Efficacy of Ganoderic Acid C1 on corticosteroid-resistant neutrophilic airway inflammation
    First Author: Wang ZZ
    Year: 2024
    Citations: 2

  • Title: Berberine inhibits inflammatory response by S. aureus in atopic eczema
    First Author: Maskey AR
    Year: 2024
    Citations: 2

  • Title: Potency and chemical consistency of FAHF-2 for food allergy treatment
    First Author: Maskey A
    Year: 2020
    Citations: 2

  • Title: The gut microbiome and cross-reactivity of food allergens
    First Author: Taico Oliva C
    Year: 2025
    Citations: 1

  • Title: Preclinical models of atopic dermatitis for therapeutic investigations
    First Author: Maskey AR
    Year: 2024
    Citations: 1

  • Title: Berberine’s potential in attenuating S. aureus-induced inflammation
    First Author: Kwan M
    Year: 2024
    Citations: 1

  • Title: 7,4 Dihydroxy Flavone for treatment of eosinophilic esophagitis
    First Author: Maskey AR
    Year: 2022
    Citations: 1

  • Title: Biomarkers and neurobiomarkers in allergic contact dermatitis
    First Author: Sasaki A
    Year: 2025
    Citations: Not listed

  • Title: Roles of bitter and sweet taste receptors in food allergy
    First Author: Xian M
    Year: 2025
    Citations: Not listed

 

Assoc Prof Dr Przemyslaw Zdziarski | Clinical immunology | Best Researcher Award

Published on by World Top Scientists

Assoc Prof. Dr Przemyslaw Zdziarski | Clinical immunology | Best Researcher Award

M.D, 1.Lower Silesian Center 2. Private Research Institute of Nature, Poland

Dr. Przemysław Zdziarski is an accomplished M.D., Ph.D., and habilitated doctor in the field of medicine, specializing in clinical immunology and infectious diseases. He graduated from the Military Medical Academy in 1996 and went on to receive a Ph.D. in medicine in 2002 for his groundbreaking research on drug hypersensitivity. Over the years, Dr. Zdziarski has made significant contributions to interdisciplinary translational medicine, collaborating with leading institutions such as the Hirszfeld Institute of Immunology and Experimental Therapy, and the Military Institute of Engineering Technology. He currently practices as a senior specialist at the Lower Silesian Oncology, Pulmonology & Hematology Center. His research areas include immunodeficiencies, immunotherapy, inflammatory adverse drug reactions, microbiome research, and oncology. He has authored over 40 publications and holds multiple patents for mobile water filtration technology. Dr. Zdziarski has earned multiple awards and distinctions for his innovative work in immunology and clinical research.

Profile 

Strengths for the Award:

Extensive and Diverse Research Background: Dr. Zdziarski’s career has spanned over two decades of significant contributions to medicine, with a focus on immunology, infectious diseases, and translational research. His work is characterized by a multidisciplinary approach, merging immunology, microbiome research, and clinical immunology to address key healthcare challenges. His research interests cover a broad spectrum, including immunodeficiencies, opportunistic infections, adverse drug reactions, vaccines, oncogenesis, and immunotherapy.

  1. Highly Productive Researcher: Dr. Zdziarski is the first author of over 40 peer-reviewed publications, many of which have made substantial contributions to the fields of immunology, infectious diseases, and pharmacovigilance. His work has been widely cited, and his papers have been recognized in leading journals. The research on immunoglobulin-induced anaphylaxis, T-cell responses, and microbiome impacts on immunotherapy, particularly in cancer and COVID-19, underscores his capacity to address emerging and critical clinical issues.
  2. Awards and Recognition: Dr. Zdziarski has received numerous awards, both for his scientific and organizational contributions. Notably, his distinctions at major international congresses (e.g., the European and World Congress of Immunology) and recognition for his work on immunomodulation in rare diseases, passive blood anaphylaxis, and the role of microbiome in disease progression highlight the high impact of his work. His scientific achievements have earned him awards at conferences in Stockholm, Berlin, and Montreal, which speak to the quality and innovation of his research.
  3. Collaborative and Interdisciplinary Approach: Dr. Zdziarski has a proven record of successful collaboration with top scientific institutions, such as the Hirszfeld Institute of Immunology, the Military Institute of Engineer Technology (WITI), and the Lower Silesian Oncology, Pulmonology & Hematology Center. His ability to work with interdisciplinary teams—combining expertise in microbiology, immunology, and clinical medicine—enables him to advance research with direct applications to clinical practice.
  4. Innovative Contributions: Beyond traditional research, Dr. Zdziarski has contributed to technological innovation, with two patents and a utility model related to mobile water filters for military and humanitarian use, demonstrating his ability to translate scientific discoveries into real-world applications.
  5. Mentorship and Leadership: As a senior specialist and consultant, Dr. Zdziarski has played a key role in shaping clinical practice and research at several institutions. His leadership in the Hospital Infections Control Team and his role as a consultant for the Polish Armed Forces and the Hirszfeld Institute of Immunology further demonstrate his influence on public health and academic development.

Areas for Improvement

  1. Broader Recognition in Clinical Immunology: While Dr. Zdziarski is well-recognized in academic circles and has contributed significantly to research in immunology and infectious diseases, there is room for further outreach to clinical practitioners, especially in the integration of his research on the microbiome and immunotherapy into daily clinical practice. Greater dissemination of his findings to the broader medical community could improve clinical outcomes.
  2. Greater Focus on Translational Impact: While Dr. Zdziarski’s work has been highly influential in academic settings, it could be beneficial to place more emphasis on the long-term translational impact of his research. Continued work to bridge the gap between laboratory findings and real-world clinical applications will solidify his position as a leader in clinical translational medicine.
  3. Diversification of Funding Sources: While Dr. Zdziarski has been involved in several prestigious collaborations, pursuing additional funding from diverse sources, such as private sector partnerships or international research foundations, could expand the scope of his work and its clinical applications.

Education 

Dr. Przemysław Zdziarski completed his medical education at the Military Medical Academy in Łódź, Poland, earning his M.D. in 1996. He further pursued research, obtaining a Ph.D. in 2002 from the same institution for his work on drug hypersensitivity. In 2003, he became a certified Infectious Disease Specialist after completing his specialization. Dr. Zdziarski continued his clinical training in clinical immunology, receiving a specialist title in 2006 after training at the Lower Silesian Center for Cellular Transplantation and the Hirszfeld Institute of Immunology and Experimental Therapy in Wrocław. In 2023, he earned his habilitation degree (post-doctoral degree) in medicine for his research on the human microbiome. Throughout his education, Dr. Zdziarski has received numerous distinctions for his academic achievements and contributions to scientific advancement. His continuous commitment to improving clinical and immunological research underscores his expertise in the medical field.

Research Focus

Dr. Przemysław Zdziarski’s research focuses on immunodeficiencies, opportunistic infections, and inflammatory adverse drug reactions. His interdisciplinary approach spans translational medicine, taking innovative scientific findings from the laboratory to real-world clinical applications. Notably, Dr. Zdziarski has contributed significantly to the field of immunotherapy, especially in the context of rare diseases and drug-induced complications. He has also expanded his research to include the human microbiome, exploring its role in various diseases and its interaction with immunological therapies. His work on drug hypersensitivity and drug-induced immune reactions has resulted in significant advances in pharmacovigilance and immunological diagnostics. Dr. Zdziarski is also an expert in oncology, with particular interest in immunooncology, and has contributed to understanding the immunological basis of tumor biology. His collaborative research across various institutions underscores his commitment to multidisciplinary approaches in advancing precision medicine.

Selected Publications 

  • Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency 🩸💉
  • Overuse of high stability antibiotics and its consequences in public and environmental health 🌍💊
  • Elizabethkingia miricola as an opportunistic oral pathogen associated with superinfectious complications in humoral immunodeficiency 🦠🦷
  • A case of stiff person syndrome: immunomodulatory effect of benzodiazepines: successful rituximab and tizanidine therapy 💊🧠
  • Detection of Polish clinical Aspergillus fumigatus isolates resistant to triazoles 🌿🔬
  • Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the European Society for Immunodeficiency 🧬💉
  • A case report of lymphoid interstitial pneumonia in common variable immunodeficiency 🫁💥
  • CMV-specific immune response—New patients, new insight: Central role of specific IgG during infancy and long-lasting immune deficiency after allogenic stem cell transplantation 🧫🧬
  • Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings 🦠🧓
  • Microbiome Analysis and Pharmacovigilance After Inhaled Glucocorticoid: Oral Dysbiosis With the Isolation of Three Rothia Species and Subsequent Sjögren’s Syndrome Development 🔬🦠

Conclusion

Dr. Przemysław Zdziarski is a highly deserving candidate for the Best Researcher Award. His outstanding scientific achievements, impactful contributions to clinical immunology and microbiome research, and his ability to innovate in healthcare technologies make him an exemplary candidate. His work has already had a significant impact on the fields of immunodeficiencies, immunotherapy, and infectious diseases. With further focus on translational research and clinical outreach, Dr. Zdziarski’s future contributions have the potential to transform medical practice, especially in the domains of precision medicine and immune-related therapies. His leadership, productivity, and commitment to scientific advancement make him an invaluable asset to the global research community.